Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3786 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Genzyme Gaucher drug improves bone density

Cerezyme, an enzyme replacement therapy, is the standard of care for patients with type 1 Gaucher disease. Patients with Gaucher disease are at increased risk for developing bone

Novo Nordisk ceases small molecule research, cuts jobs

Since 2002, Novo Nordisk has increased its focus on pharmaceuticals based on therapeutic proteins, and the company's pipeline of protein-based pharmaceuticals within diabetes, haemostasis, growth disorders and other

Actelion hypertension drug successful

The study indicated that six months of treatment with Tracleer showed a significant reduction in pulmonary vascular resistance, a primary endpoint of the study. Patients also showed a

Newron wins patent dispute

The dispute was between Newron and Purdue Neuroscience concerning a class of chemical compounds. Newron alone will retain patent claims to methods of treating pain including this class

GM chickens lay anti-cancer eggs

The Roslin Institute modified the chickens with human genes enabling the birds to lay eggs that can produce anti-cancer drugs. The Institute said the drugs were contained within